This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Elanco, Bayer say most players CADE queried are positive or neutral about their deal

By Ana Paula Candil ( April 9, 2020, 20:46 GMT | Insight) -- Elanco Animal Health and Bayer have told the Brazilian competition authority that a market inquiry conducted by the agency has shown that their deal won't harm competition. The parties said that most of the 63 players who have responded to the agency so far presented neutral or positive opinions about Elanco’s planned buyout of Bayer's animal health business. Elanco Animal Health and Bayer have told the Brazilian competition authority that a market inquiry conducted by the agency has shown that their deal won't harm competition. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login